Amarin Corp PLC (STU:EH3A)
€ 0.442 -0.038 (-7.92%) Market Cap: 197.44 Mil Enterprise Value: -83.88 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 38/100

Amarin Corporation PLC at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 02:30PM GMT
Release Date Price: €3.96 (+2.59%)
Paul Choi
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good morning. We'll continue with the next session. I'm Paul Choi, SMID-Cap biotechnology analyst here at Goldman Sachs. It's my pleasure to introduce the management team from Amarin. With us today, we have John Thero and Karim Mikhail.

What we'll do is continue with the standard format. We'll let -- have John kick it off with some introductory remarks, and then we'll get into the Q&A. If clients along the way have questions, please feel free to e-mail them through the research portal here or to e-mail them to me directly, and time permitting, I will ask the management team the questions.

And with that, I'll turn it over to John.

John Thero

Thanks, Paul, and thanks, everybody, for joining us here today. First, let me just state, I -- during this presentation, both Karim and I will be making forward-looking statements. There are risks involved with any such forward-looking statements, and investors should review our SEC filings before investing.

This is an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot